Hamilton Lane Advisors’s MacroGenics MGNX Stock Holding History

Hamilton Lane Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-9,201	Closed	-$323K	–	57
2014 Q4	$323K	Buy	+9,201	New	+$229K	0.12%	45

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Hamilton Lane Advisors's MGNX Position: Q1 2015 in Review

Hamilton Lane Advisors sold out of MacroGenics (MGNX) in Q1 2015, closing a stake of 9,201 shares — an estimated $323K sold.

Hamilton Lane Advisors first reported a position in MGNX in Q4 2014 and held it in 1 quarter. The position peaked at $323K in Q4 2014. 113 funds tracked by Wall St. Rank hold MGNX as of Q1 2015.

Hamilton Lane Advisors reported no remaining MacroGenics position as of Q1 2015 after selling out during the quarter.
Hamilton Lane Advisors sold 9,201 MacroGenics shares in Q1 2015, an estimated $323K.
Hamilton Lane Advisors first reported a position in MacroGenics in Q4 2014 and held it in 1 quarter.
Hamilton Lane Advisors's MacroGenics position peaked at $323K in Q4 2014.
113 funds tracked by Wall St. Rank held MacroGenics as of Q1 2015.

Based on Hamilton Lane Advisors's 13F filing for Q1 2015, filed 8 Apr 2015.